Cheryl Healton

Cheryl Healton
Cheryl Healton

Founding Dean of School of Global Public Health

Professor of Public Health Policy and Management

Professional overview

For the last ten years, Dean Healton has devoted herself to building GPH’s academic, service, and research programs. The School has been accredited by CEPH, increased the size of its student body and research funding, recruited top faculty, added doctoral-level programs, and made diversity, equity and inclusion a priority.

Previously, as the founding President and CEO of Legacy, a leading organization dedicated to tobacco control, Dean Healton guided the national youth tobacco prevention campaign, which has been credited with reducing youth smoking prevalence to record lows, and launched programs for smoking cessation, public education, technical assistance, and a broad range of grant making.

Prior to joining Legacy, Dean Healton held numerous roles at Columbia University including Associate Dean of its Medical School, Assistant Vice President for the Health Sciences and Chairman of Sociomedical Sciences, and Associate Dean of the Mailman School of Public Health. She is an Emeritus Professor of Columbia University.

Dean Healton has authored over 120 peer-reviewed articles and has been awarded multiple grants in AIDS, tobacco control and higher education. She was the founding chair of the Public Health Practice Council of the Association of Schools of Public Health. As an active member of the public health community she has given presentations around the world and is a frequent contributor to national and local coverage of public health issues.

She holds a DrPH from Columbia University's School of Public Health (with distinction) and a Master’s in Public Administration from the Robert F. Wagner Graduate School of Public Service at NYU.

Education

MPA, Health Policy and Planning, New York University, New York, NY
DrPH, Sociomedical Sciences (with distinction), Columbia University, New York, NY

Areas of research and study

Public Health Law
Public Health Policy
Tobacco Control

Publications

Publications

Barriers to Cervical Cancer Screening and Treatment in the Dominican Republic: Perspectives of Focus Group Participants in the Santo Domingo Area

Parent-Level Barriers and Facilitators to HPV Vaccine Implementation in Santo Domingo, Dominican Republic

Racial/Ethnic Diversity in Academic Public Health: 20-Year Update

Evidence, alarm, and the debate over e-cigarettes

Fairchild, A., Healton, C., Curran, J., Abrams, D., & Bayer, R. (n.d.).

Publication year

2019

Journal title

Science

Volume

366

Issue

6471

Page(s)

1318-1320

The tobacco master settlement agreement - Strategic lessons for addressing public health problems

Pedagogical Scholarship in Public Health: A Call for Cultivating Learning Communities to Support Evidence-Based Education

The US Cancer Moonshot initiative

Tobacco control: How are we doing?

Robbing Peter to Pay Paul with our Lives, Huffington

To be ready for Ebola, hospitals need proper equipment, training and a plan

Healton, C., & Ogedegbe, O. (n.d.).

Publication year

2015

Journal title

The Huffington Post

Tobacco control since the 1964 Surgeon General's Report: Reflecting back and looking forward

Mulshine, J. L., & Healton, C. (n.d.).

Publication year

2014

Journal title

ONCOLOGY (United States)

Volume

28

Issue

3

What would it really take to halt Ebola and prevent future epidemics?

Public attitudes regarding banning of cigarettes and regulation of nicotine

Who will deliver on the promise?

Depictions of tobacco use in 2007 broadcast television programming popular among US youth

The Tobacco Technical Assistance Consortium: a foundation-university partnership to reduce tobacco use.

Tobacco and NIH: More than addiction

Tobacco: An equal-opportunity killer?

US attitudes about banning menthol in cigarettes: Results from a nationally representative survey

Winickoff, J. P., McMillen, R. C., Vallone, D. M., Pearson, J. L., Tanski, S. E., Dempsey, J. H., Healton, C., Klein, J. D., & Abrams, D. (n.d.).

Publication year

2011

Journal title

American journal of public health

Volume

101

Issue

7

Page(s)

1234-1236
Abstract
Abstract
Menthol is a cigarette flavoring that makes smoking more appealing to smokers. The US Food and Drug Administration (FDA) has regulatory authority to ban mentholated cigarettes to reduce youth uptake and encourage adult cessation. Survey findings indicate that more than half of all Americans (56.1%) and of Blacks alone (68.0% in one sample and 75.8% in another) support banning menthol. Endorsement of a ban-especially by Blacks, who have the highest rates of menthol cigarette use-would support FDA action to ban menthol to protect the public's health.

Camel No. 9 cigarette-marketing campaign targeted young teenage girls

Home and workplace smoking bans in Italy, Ireland, Sweden, France and the Czech Republic

Menthol Cigarettes are Harmful

Misinformation about tobacco

Prohibiting menthol in tobacco products: A policy whose time has come

The truth® Campaign: Using Countermarketing to Reduce Youth Smoking

Contact

cheryl.healton@nyu.edu 708 Broadway 8FL New York, NY, 10003